Published in Indian J Pharmacol on April 01, 2013
Endothelial function testing as a biomarker of vascular disease. Circulation (2003) 2.30
A common variant of the endothelial nitric oxide synthase (Glu298-->Asp) is a major risk factor for coronary artery disease in the UK. Circulation (1999) 2.29
Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A (2000) 2.21
The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. J Am Coll Cardiol (2003) 1.97
Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm. Circulation (1997) 1.82
Photoplethysmographic assessment of pulse wave reflection: blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus. J Am Coll Cardiol (1999) 1.72
Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am J Epidemiol (2006) 1.66
Functional gene testing of the Glu298Asp polymorphism of the endothelial NO synthase. J Hypertens (2000) 1.49
Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function. Circ Res (2002) 1.46
Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol (2002) 1.40
Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension (1999) 1.04
Assessment of endothelial function: comparison of the pulse wave response to beta 2-adrenoceptor stimulation with flow mediated dilatation. Br J Clin Pharmacol (2007) 0.92
The effects of endothelial nitric oxide synthase gene polymorphisms on endothelial function and metabolic risk factors in healthy subjects: the significance of plasma adiponectin levels. Eur J Endocrinol (2008) 0.89
Digital pulse plethysmography (DPG) in studies of the hemodynamic response to nitrates--a survey of recording methods and principles of analysis. Acta Pharmacol Toxicol (Copenh) (1986) 0.87
The functional consequence of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene in young healthy volunteers. Cardiovasc Drug Rev (2007) 0.87
Gender specific association of endothelial nitric oxide synthase gene (Glu298Asp) polymorphism with essential hypertension in a south Indian population. Clin Chim Acta (2008) 0.85
Association analysis of endothelial nitric oxide synthase gene polymorphism with primary hypertension in a Singapore population. J Hum Hypertens (2006) 0.85
Lack of association between the Glu298Asp variant of the endothelial nitric oxide synthase gene and the risk of coronary artery disease among Taiwanese. J Formos Med Assoc (2001) 0.85
Endothelium-derived nitric oxide partially mediates salbutamol-induced vasodilatations. Eur J Pharmacol (1993) 0.84
Association of endothelial nitric oxide synthase promoter region (T-786C) gene polymorphism with acute coronary syndrome and coronary heart disease. Lipids Health Dis (2008) 0.83
Lack of association between Glu(298) asp polymorphism of endothelial nitric oxide synthase (eNOS) gene and coronary artery disease in Tamilian population. Indian Heart J (2009) 0.83
Prevalence of beta-2 adrenergic receptor (beta 2 AR) polymorphisms and its influence on a model used to assess endothelial function using pulse wave analysis (PWA). Clin Chim Acta (2009) 0.78
CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population. Fundam Clin Pharmacol (2005) 1.15
Globalization of clinical trials - where are we heading? Curr Clin Pharmacol (2013) 0.94
Severe phenytoin toxicity in a CYP2C9*3*3 homozygous mutant from India. Neurol India (2007) 0.93
Body mass index contributes to sympathovagal imbalance in prehypertensives. BMC Cardiovasc Disord (2012) 0.88
A single-nucleotide polymorphism in the MDR1 gene as a predictor of response to neoadjuvant chemotherapy in breast cancer. Clin Breast Cancer (2009) 0.86
Gender specific association of endothelial nitric oxide synthase gene (Glu298Asp) polymorphism with essential hypertension in a south Indian population. Clin Chim Acta (2008) 0.85
CYP1A1 polymorphisms and the risk of upper aerodigestive tract cancers in an Indian population. Head Neck (2008) 0.85
Antiproliferative property of n-hexane and chloroform extracts of Anisomeles malabarica (L). R. Br. in HPV16-positive human cervical cancer cells. J Pharmacol Pharmacother (2012) 0.85
Allele and genotype frequency of MDR1 C3435T in Tamilian population. Drug Metab Pharmacokinet (2006) 0.84
Lack of association between Glu(298) asp polymorphism of endothelial nitric oxide synthase (eNOS) gene and coronary artery disease in Tamilian population. Indian Heart J (2009) 0.83
Influence of CYP2C9 genetic polymorphism and undernourishment on plasma-free phenytoin concentrations in epileptic patients. Ther Drug Monit (2010) 0.81
Genetic variations and haplotypes of the 5' regulatory region of CYP2C19 in South Indian population. Drug Metab Pharmacokinet (2009) 0.81
Gene-gene interactions of drug metabolizing enzymes and transporter protein in the risk of upper aerodigestive tract cancers among Indians. Cancer Epidemiol (2010) 0.80
Functional characterization of promoter region polymorphisms of human CYP2C19 gene. Mol Biol Rep (2010) 0.80
ABCB1 genetic polymorphism and risk of upper aerodigestive tract cancers among smokers, tobacco chewers and alcoholics in an Indian population. Pharmacogenet Genomics (2007) 0.79
Endothelial nitric oxide synthase gene polymorphisms and the risk of acute myocardial infarction in a South Indian population. Mol Biol Rep (2012) 0.79
Influence of the genetic polymorphisms in the 5' flanking and exonic regions of CYP2C19 on proguanil oxidation. Drug Metab Pharmacokinet (2009) 0.78
Influence of Sokal, Hasford, EUTOS scores and pharmacogenetic factors on the complete cytogenetic response at 1 year in chronic myeloid leukemia patients treated with imatinib. Med Oncol (2015) 0.78
Relative Copy Number Variations of CYP2C19 in South Indian Population. Mol Biol Int (2012) 0.77
Gene-environment interactions associated with CYP1A1 MspI and GST polymorphisms and the risk of upper aerodigestive tract cancers in an Indian population. J Cancer Res Clin Oncol (2009) 0.77
Ethics of genomic research. Perspect Clin Res (2013) 0.75